Market Research Reports and Industry Reports

France Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the French cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

French Market Overview

- Five-year test volume and sales projections. - Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers. - Estimated universe of laboratories performing cancer diagnostic testing. - Cancer statistics, etiology and recent developments in France.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes - Biochemical Markers - Growth Factors - Colony Stimulating Factors - Hormones - Immunohistochemical Stains - Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test.

- Five-year test volume and sales forecasts for major tumor markers by market segment, including:

     º  Hospitals      º  Commercial/Private Laboratories

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing. - Review of competing/complementing technologies. - Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - AdnaGen    - Agilent Technologies    - Applied Gene Technologies    - Arca Biopharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biomedical Diagnostics    - bioMerieux    - Bio-Rad    - CellSearch    - Cepheid    - Correlogic Systems/Vermillion    - Decode Genetics    - Diadexus    - Diagnocure    - DiaSorin    - Eiken Chemical    - Elitech Group    - Enterix    - Enzo Biochem    - Epigenomics    - Exact Sciences    - Fujirebio    - Guided Therapeutics    - Hologic/Gen-Probe    - Kreatech/Leica    - Kyowa Medex    - Mackay Life Sciences    - Myriad Genetics    - OncoLab    - Ortho-Clinical Diagnostics    - Panacea Pharmaceuticals    - Polartechnics    - Polymedco    - PreMD    - Qiagen    - Quest Diagnostics    - Radient Pharmaceuticals    - Roche    - Scienion    - Sequenom    - Siemens Healthcare    - Takara Bio    - Targeted Diagnostics & Therapeutics    - Thermo Fisher    - Tosoh    - Veridex    - Wako Pure Chemicals    - Wallac/PE    - Zilla

 I. Introduction

II. Worldwide Market Overview

A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

III. Major Product Development Opportunities

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Worldwide Market and Technology Overview

A. Major Current and Emerging Cancer Diagnostic Tests

1. Biochemical Tumor Markers
2. Oncogenes
3. Polypeptide Growth Factors
4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing

VIII. France

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares

IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca
Biop
harma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group 
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen/Ipsogen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh 
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

X.Appendix: 

Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications


List Of Tables

Cancer Diagnostic Classification

Major Companies Developing or Marketing

ACTH Tests

Major Companies Developing or Marketing

AFP Tests

Major Companies Developing or Marketing

Beta-2 Microglobulin Tests

Major Companies Developing or Marketing

CA 15-3/27.29 Tests

Major Companies Developing or Marketing

CA 19-9 Tests

Major Companies Developing or Marketing

CA 125 Tests

Major Companies Developing or Marketing

Calcitonin Tests

Major Companies Developing or Marketing

CEA Tests

Major Companies Developing or Marketing

Estrogen Receptor Tests

Major Companies Developing or Marketing

Progesterone Receptor Tests

Major Companies Developing or Marketing

Ferritin Tests

Major Companies Developing or Marketing

Gastrin Tests

Major Companies Developing or Marketing

HCG Tests

Major Companies Developing or Marketing

Insulin Tests

Major Companies Developing or Marketing

NSE Tests

Major Companies Developing or Marketing

Occult Blood Tests

Major Companies Developing or Marketing

PAP Smear/HPV Tests

Major Companies Developing or Marketing

PAP Tests

Major Companies Developing or Marketing

PSA Tests

Major Companies Developing or Marketing

Lymphocyte Subclassification Tests

Biochemical Markers Potential Applications

In Cancer Diagnosis

Oncogenes Potential Applications

In Cancer Diagnosis

Major Companies Developing or Marketing

Oncogene Tests

Growth Factors Potential Applications

In Cancer Diagnosis

Colony Stimulating Factors Potential

Applications in Cancer Diagnosis

Lymphokines Potential Applications In Cancer Diagnosis

Immunohistochemical Stains Potential

Applications in Cancer Diagnosis

Executive Summary Table: France, Total Cancer

Diagnostic Testing Volume and Sales Forecasts

by Market Segment

France, Estimated Cancer Death Rates

France, Laboratories Performing Cancer

Diagnostic Tests by Market Segment

France, Hospital Laboratories Performing

Cancer Diagnostic Tests by Bed Size

France, Commercial/Private Laboratories

Performing Cancer Diagnostic Test by Annual Test Volume

France, Total Cancer Diagnostic Test Volume

Forecasts by Market Segment

France, All Market Segments Major Cancer

Diagnostic Test Volume Forecasts by Test

France, Hospital Laboratories Major Cancer

Diagnostic Test Volume Forecasts by Test

France, Commercial/Private Laboratories

Marker Test Volume Forecasts

France, Total Cancer Diagnostic Sales Major Cancer Diagnostic

Forecasts by Market Segment

France, All Market Segments Major Cancer

Diagnostic Sales Forecasts by Test

France, Hospital Laboratories Major Cancer

Diagnostic Sales Forecasts by Test

France, Commercial/Private Laboratories Cancer

Diagnostic Market Forecasts by Test

France, ACTH Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, AFP Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, Beta-2 Microglobulin Test Volume and

Diagnostics Sales Forecasts by Market Segment

France, CA 15-3/27.29 Test Volume and

Diagnostics Sales Forecasts by Market Segment

France, CA 19-9 Test Volume and Diagnostics

Sales Forecasts by Market

France, CA-125 Test Volume and Diagnostics

Sales Forecasts by Market Segment

France, Calcitonin Test Volume and Diagnostics

Sales Forecasts by Market Segment

France, Cathepsin Test Volume and Diagnostics

Sales Forecasts by Market Segment

France, CEA Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, Colon-Specific Antigen Test Volume

And Diagnostics Sales Forecasts by Market Segment

France, Cytokeratins Test Volume and

Diagnostics Sales Forecasts by Market Segment

 

France, Estrogen Receptor Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Ferritin Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Gastrin Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, HCG Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, Insulin Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Interferons Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Interleukins Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Lymphocyte Subtyping Test Volume

And Diagnostics Sales Forecasts by Market

Segment

France, NSE Test Volume and Diagnostics

Sales Forecasts by Market Segment

France, Nucleolar Test Volume and Diagnostics

Sales Forecasts by Market Segment

France, Occult Blood Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Oncogenes Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Pancreatic Oncofetal Antigen

Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, PAP Smear Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Parathyroid Hormone Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Progesterone Receptor Test Volume

And Diagnostics Sales Forecasts by Market

Segment

France, PAP Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, PSA Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, S-100 Protein Test Volume and Sales

Diagnostics Sales Forecasts by Market

Segment

France, Serotonin Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Sialic Acid Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, Squamous Cell Carcinoma Antigen

Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, TDT Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, Thymidine Kinase Test Volume

And Diagnostics Sales Forecasts by

Market Segment

France, Thyroglobulin Test Volume and

Diagnostics Sales Forecasts by Market

Segment

France, TPA Test Volume and Diagnostics Sales

Forecasts by Market Segment

France, Total Cancer Diagnostics Sales

By Major Suppliers

France, AFP Testing Market Diagnostics

Sales by Major Supplier

France, CA 15-3 Testing Market Diagnostics

Sales by Major Supplier

France, CA 19-9 Testing Market Diagnostics

Sales by Major Supplier

France, CA 125 Testing Market Diagnostics

Sales by Major Supplier

France, CEA Testing Market Diagnostics

Sales by Major Supplier

France, NSE Testing Market Diagnostics

Sales by Major Supplier

France, PAP Testing Market Diagnostics

Sales by Major Supplier

France, PSA Testing Market Diagnostics

Sales by Major Supplier

 


List Of Figures

A


Sobegi – Béarn Biomass Cogeneration Power Plant – France - Construction Project Profile

Synopsis Sobegi Barn Biomass Cogeneration Power Plant France contains information on the scope of the project including project overview and location. The profile also details project ownership and funding,

USD 75View Report

ADP – Paris Charles de Gaulle Airport Terminal 4 – France - Construction Project Profile

Synopsis ADP Paris Charles de Gaulle Airport Terminal 4 France contains information on the scope of the project including project overview and location. The profile also details project ownership

USD 75View Report

Electricite de France S.A. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Electricite de France S.A. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Global Cancer Diagnostics Device Sales Market Report 2016

Notes:Sales, means the sales volume of Cancer Diagnostics DeviceRevenue, means the sales value of Cancer Diagnostics DeviceThis report studies sales (consumption) of Cancer Diagnostics Device in Global market, especially in

USD 4000View Report

Global Cancer Diagnostics Device Market Research Report 2016

Notes:Production, means the output of Cancer Diagnostics DeviceRevenue, means the sales value of Cancer Diagnostics DeviceThis report studies Cancer Diagnostics Device in Global market, especially in North America, Europe, China,

USD 2900View Report

2016 Switzerland Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends

USD 4850View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 6700    $ 6700
  • Global Licence $ 14700    $ 14700
  • DataPack $ 4350    $ 4350
$ 6700

Reports Details

Published Date : Aug 2016
No. of Pages :585
Country :France
Category :Healthcare
Publisher :VPGMarketResearch.com
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment